U.S., Nov. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07917637) titled 'Ashwagandha Added to Risperidone for Quality of Life and Inflammation in Schizophrenia' on Oct. 31.
Brief Summary: Schizophrenia is a chronic mental health disorder that affects thinking, emotions, behavior, and quality of life. Although antipsychotic medications such as risperidone are commonly used to manage schizophrenia, some patients continue to experience psychiatric symptoms and reduced quality of life. Inflammation may also contribute to the development and severity of schizophrenia.
Ashwagandha (Withania somnifera) is a medicinal plant with potential anti-inflammatory and neuroprotective properties. This study evaluated whe...